Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Schizophrenia

Free Subscription 17.06.2024 1 Acta Psychiatr Scand 2 Biol Psychiatry 1 Cortex 2 Mol Psychiatry 1 Nat Genet 1 Neuropsychopharmacology 1 Psychiatry Res 30 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Psychiatr Scand

1. BERKHOF M, van der Stouwe ECD, Pot-Kolder RMCA, van der Gaag M, et al
   Exploring the role of clinical and demographic characteristics on the effects of virtual reality cognitive behavioral therapy for psychosis: A moderator analysis.
   Acta Psychiatr Scand. 2024 Jun 9. doi: 10.1111/acps.13713.
   PubMed         Abstract available
   
   

   
   Biol Psychiatry

2. JIAO X, Hu Q, Tang Y, Zhang T, et al
   Abnormal Global Cortical Responses in Drug-naive Patients with Schizophrenia following Orbitofrontal Cortex Stimulation: A Concurrent TMS-EEG Study.
   Biol Psychiatry. 2024 Jun 7:S0006-3223(24)01364.
   PubMed         Abstract available
   
   
3. KRAKOWSKI K, Oliver D, Arribas M, Stahl D, et al
   Dynamic and transdiagnostic risk calculator based on Natural Language Processing for the prediction of psychosis in secondary mental health care: development and internal-external validation cohort study.
   Biol Psychiatry. 2024 Jun 7:S0006-3223(24)01361.
   PubMed         Abstract available
   
   

   
   Cortex

4. CONNORS MH, Gibbs J, Large MM, Halligan PW, et al
   Delusions in postpartum Psychosis: Implications for cognitive theories.
   Cortex. 2024;177:194-208.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

5. CAMPORESI S, Xin L, Golay P, Eap CB, et al
   Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study.
   Mol Psychiatry. 2024 Jun 7. doi: 10.1038/s41380-024-02631.
   PubMed         Abstract available
   
   
6. OKADA N, Yahata N, Koshiyama D, Morita K, et al
   Longitudinal trajectories of anterior cingulate glutamate and subclinical psychotic experiences in early adolescence: the impact of bullying victimization.
   Mol Psychiatry. 2024;29:939-950.
   PubMed         Abstract available
   
   

   
   Nat Genet

7. FREI O, Hindley G, Shadrin AA, van der Meer D, et al
   Improved functional mapping of complex trait heritability with GSA-MiXeR implicates biologically specific gene sets.
   Nat Genet. 2024;56:1310-1318.
   PubMed         Abstract available
   
   

   
   Neuropsychopharmacology

8. CHENOWETH MJ
   Cracking the chicken and egg problem of schizophrenia and substance use: Genetic interplay between schizophrenia, cannabis use disorder, and tobacco smoking.
   Neuropsychopharmacology. 2024 Jun 11. doi: 10.1038/s41386-024-01898.
   PubMed        
   
   

   
   Psychiatry Res

9. BUCCI S, Berry N, Ainsworth J, Berry K, et al
   Effects of Actissist, a digital health intervention for early psychosis: A randomized clinical trial.
   Psychiatry Res. 2024;339:116025.
   PubMed         Abstract available
   
   

   
   Schizophr Res

10. VERDOUX H, Quiles C, de Leon J
    Risks and benefits of clozapine and lithium co-prescribing: A systematic review and expert recommendations.
    Schizophr Res. 2024;268:233-242.
    PubMed         Abstract available
    
    
11. RUAN CJ, Wang CY, Zang YN, Liu CG, et al
    A brief history of clozapine in China with a look forward.
    Schizophr Res. 2024;268:25-28.
    PubMed         Abstract available
    
    
12. SCHORETSANITIS G, Anil Yagcioglu AE, Ruan CJ, Eap CB, et al
    Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition.
    Schizophr Res. 2024;268:302-307.
    PubMed         Abstract available
    
    
13. KIKUCHI Y, Komatsu H, Otsuka Y, Ito F, et al
    Slower clozapine titration than the official Japanese protocol led to fewer inflammatory adverse effects: A retrospective chart review of seven hospitals.
    Schizophr Res. 2024;268:98-106.
    PubMed         Abstract available
    
    
14. GROVER S, Naskar C
    Patient and caregivers perspective about clozapine: A systematic review.
    Schizophr Res. 2024;268:223-232.
    PubMed         Abstract available
    
    
15. LIN SK, Lane HY
    A brief history of clozapine use in Taiwan.
    Schizophr Res. 2024;268:34-37.
    PubMed         Abstract available
    
    
16. RUAN CJ, Olmos I, Ricciardi C, Schoretsanitis G, et al
    Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies.
    Schizophr Res. 2024;268:293-301.
    PubMed         Abstract available
    
    
17. CLARK SR, Wilton LR, Dawson JL, Chiew K, et al
    Dotting the I's and crossing the T's: A South Australian perspective on variability in troponin thresholds for myocarditis risk in clozapine treatment.
    Schizophr Res. 2024;268:114-117.
    PubMed        
    
    
18. KELLY DL, Glassman M, Wonodi I, Vyas G, et al
    Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial.
    Schizophr Res. 2024;268:312-322.
    PubMed         Abstract available
    
    
19. LEUNG JG, Allen ND, Markota M
    A case series of clozapine titrations affected by inflammatory processes.
    Schizophr Res. 2024;268:94-97.
    PubMed        
    
    
20. DE LEON J, Wang L, Simpson GM
    The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences.
    Schizophr Res. 2024;268:14-20.
    PubMed         Abstract available
    
    
21. CARSWELL O, Wilton LR, Nicholls K, Thomas V, et al
    A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titration.
    Schizophr Res. 2024;268:88-93.
    PubMed         Abstract available
    
    
22. KIRILOCHEV O, Chumakov E, Kuzo N, Schoretsanitis G, et al
    A scoping review of literature on clozapine from former USSR states published in Russian language.
    Schizophr Res. 2024;268:38-47.
    PubMed         Abstract available
    
    
23. SCHULTE PFJ, Veerman SRT, Bakker B, Bogers JPAM, et al
    Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?
    Schizophr Res. 2024;268:74-81.
    PubMed         Abstract available
    
    
24. SANKARANARAYANAN A, Kazi S, Andrade C
    Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia.
    Schizophr Res. 2024;268:145-149.
    PubMed         Abstract available
    
    
25. SAGUD M, Breznoscakova D, Celofiga A, Chihai J, et al
    An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance.
    Schizophr Res. 2024;268:53-59.
    PubMed         Abstract available
    
    
26. MUNOZ-MANCHADO LI, Perez-Revuelta JI, Banerjee A, Galindo-Guarin L, et al
    Influence of time to clozapine prescription on the clinical outcome.
    Schizophr Res. 2024;268:189-192.
    PubMed         Abstract available
    
    
27. YANG Z, Takeuchi H, Yee JY, See YM, et al
    Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore.
    Schizophr Res. 2024;268:66-73.
    PubMed         Abstract available
    
    
28. ZOLEZZI M, Eltorki Y
    A brief history and challenges of clozapine utilization in the Arab world.
    Schizophr Res. 2024;268:21-24.
    PubMed        
    
    
29. VERDOUX H, Quiles C, de Leon J
    Optimizing antidepressant and clozapine co-prescription in clinical practice: A systematic review and expert recommendations.
    Schizophr Res. 2024;268:243-251.
    PubMed         Abstract available
    
    
30. MEYER JM
    Making sense of norclozapine levels: 3 clinical axioms.
    Schizophr Res. 2024;268:289-292.
    PubMed         Abstract available
    
    
31. KUZO N, Blyzniuk B, Chumakov E, Seifritz E, et al
    Clozapine research standards in former USSR states: A systematic review of quality issues with recommendations for future harmonization with modern research standards.
    Schizophr Res. 2024;268:48-52.
    PubMed         Abstract available
    
    
32. BAPTISTA T, Motuca M, Serrano A, Perez Lo Presti A, et al
    An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance.
    Schizophr Res. 2024;268:60-65.
    PubMed         Abstract available
    
    
33. NIITSU T, Yasui-Furukori N, Inada K, Kanazawa T, et al
    Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey.
    Schizophr Res. 2024;268:82-87.
    PubMed         Abstract available
    
    
34. DE LEON J
    Promoting safer and wider worldwide use of clozapine.
    Schizophr Res. 2024;268:1-6.
    PubMed         Abstract available
    
    
35. MUKAI Y, Lupinacci R, Marder S, Snow-Adami L, et al
    Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial.
    Schizophr Res. 2024;270:37-43.
    PubMed         Abstract available
    
    
36. CECERSKA-HERYC E, Polikowska A, Serwin N, Michalczyk A, et al
    The importance of oxidative biomarkers in diagnosis, treatment, and monitoring schizophrenia patients.
    Schizophr Res. 2024;270:44-56.
    PubMed         Abstract available
    
    
37. SANDSTEN KE, Jensen MT, Saebye D, Null K, et al
    Altered cardiac autonomic functioning associates with self-disorders in schizophrenia.
    Schizophr Res. 2024;270:57-62.
    PubMed         Abstract available
    
    
38. DEFAYETTE AB, Silverstein SM, Pisani AR
    Social network structure as a biopsychosocial suicide prevention target for young people at clinical high-risk for psychosis.
    Schizophr Res. 2024;270:63-67.
    PubMed         Abstract available
    
    
39. MOROSAN L, de Almeida ER, van der Tuin S, van den Berg D, et al
    The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis.
    Schizophr Res. 2024;270:76-84.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.